Life after Vioxx: the clinical implications
| Autor: | Christopher J. Hawkey, Paul Fortun |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Clinical Trials as Topic
medicine.medical_specialty Nonsteroidal Gastrointestinal Diseases business.industry Anti-Inflammatory Agents Non-Steroidal MEDLINE Alternative medicine General Medicine Risk Assessment Arthritis Rheumatoid Toxicology Lactones chemistry.chemical_compound chemistry Cardiovascular Diseases Risk Factors medicine Humans Cyclooxygenase Inhibitors Sulfones Intensive care medicine Risk assessment business |
| Zdroj: | British Journal of Hospital Medicine. 66:264-267 |
| ISSN: | 1759-7390 1750-8460 |
| Popis: | The withdrawal of Vioxx, as a result of concerns regarding cardiovascular risk, has left unanswered questions about the safety of COX-2 inhibitors and nonsteroidal anti-inflammatory drugs (NSAIDs) in general. However, to what extent should the concerns about Vioxx be extended to other anti-inflammatory drugs? |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|